First human tests begin for potential new gout pill
NCT ID NCT07324434
Summary
This is an early-stage study to check the safety and dosing of a new oral tablet called F-02-2-Na for people with high uric acid, with or without gout. The trial will enroll 69 healthy adults and adults with high uric acid to test single and multiple doses. The main goal is to see how safe the drug is and how it is processed by the body, not to treat the condition yet.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERURICEMIA WITH OR WITHOUT GOUT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510120, China
Conditions
Explore the condition pages connected to this study.